Litecoin (LTC) has surged to $119.30 after breaking key resistance at $116, fueled by record transaction volumes and growing ...

The August crypto market is alive with rotation. XRP investors and Litecoin holders are reallocating funds after a period of ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Litecoin surges 10% in 24 hours, breaking a 3-year consolidation pattern while gaining prominence as a payment option and ...

With momentum and trading volume rising 230% to reach $1.97 billion, the rally remains strong. If sustained, LTC could reclaim its 2025 high of $141.15 and possibly extend to its December 2024 peak of ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

CoinGate data shows Litecoin is now the second most used cryptocurrency for payments, just behind Bitcoin, thanks to its fast ...

Speculation over a spot ETF continues to build despite the SEC delaying its decision on Grayscale’s application until October.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

There is significant market optimism, with analysts assigning a 90-95% probability that the U.S. SEC will approve a spot Litecoin (LTC) ETF by October 2025. This positive outlook is primarily driven ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...